)
)
Neuronetics Investor Relations Material
Latest events
Q2 2024
Neuronetics
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Neuronetics Inc
Access all reports
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. It offers NeuroStar advanced therapy system that enables physicians to provide office-based treatments for adult patients suffering from major depressive disorder (MDD); and maintains a registry of clinical outcomes of MDD treatment using the system. The company was founded in 1997 and is headquartered in Malvern, Pennsylvania.
Key slides for Neuronetics Inc
Q2 2024
Neuronetics Inc
Q2 2024
Neuronetics Inc
Latest articles
)
Cristiano Amon: Qualcomm's 5G Specialist CEO
Cristiano Amon, Qualcomm CEO, has spent two decades at the company while taking on several roles, developing both technical and business expertise.
16 Sep 2024
)
Qualcomm: Quality Communication and Semiconductor Innovation
Founded in 1985, Qualcomm has transformed the digital communication industry with CDMA technology and its advanced semiconductor business.
13 Sep 2024
)
Strong Opinions, Loosely Held: Pontus Dackmo on Flexibility and Market Psychology
After a two-decade career in finance, Pontus Dackmo co-founded Protean Funds Scandinavia in 2022, where he now serves as CEO and Investment Manager.
4 Sep 2024
Ticker symbol
STIM
Country
🇺🇸 United States